The essential role of glucocorticoids for proper human osteoblast differentiation and matrix mineralization

被引：99

作者：

Eijken, M ^{[1
]}

Koedam, M ^{[1
]}

van Driel, M ^{[1
]}

Buurman, CJ ^{[1
]}

Pols, HAP ^{[1
]}

van Leeuwen, JPTM ^{[1
]}

机构：

[1] Eramus MC, Dept Internal Med, NL-3000 DR Rotterdam, Netherlands

来源：

MOLECULAR AND CELLULAR ENDOCRINOLOGY | 2006年 / 248卷 / 1-2期

关键词：

glucocorticoids dexamethasone; osteoblast; differentiation; mineralization; 11 beta-hydroxysteroid dehydrogenase;

D O I：

10.1016/j.mce.2005.11.034

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

Glucocorticoids (GCs) exert profound effects on bone and are essential for human osteoblast differentiation. However, GCs are still interpreted as negative regulators of bone formation, mainly caused by the detrimental effects on bone after clinical use of GCs. In this paper we emphasize the importance of GCs for proper human osteoblast differentiation and matrix mineralization. We show that human osteoblast differentiation needs to be triggered by GCs in a specific time-window during the early stages of development. Exposure to GCs in the beginning of osteoblast development induces a dose dependent increase in alkaline phosphatase activity and matrix mineralization. GC-induced differentiation stimulated expression of genes involved in bone formation and suppressed genes that negatively regulate bone formation and mineralization. Furthermore we highlight the importance of local cortisol activation in osteoblasts by expression of 11 beta-hydroxysteroid dehydrogenase 1 (11 beta-HSD1). (c) 2005 Elsevier Ireland Ltd. All rights reserved.

引用

页码：87 / 93

页数：7

共 52 条

[1] Proliferation and differentiation of osteoblasts and adipocytes in rat bone marrow stroma cell cultures: Effects of dexamethasone and calcitriol [J].

Atmani, H ;

Chappard, D ;

Basle, MF .

JOURNAL OF CELLULAR BIOCHEMISTRY, 2003, 89 (02) :364-372

[2] PHYSIOLOGICAL CONCENTRATIONS OF GLUCOCORTICOIDS STIMULATE FORMATION OF BONE NODULES FROM ISOLATED RAT CALVARIA CELLS-INVITRO [J].

BELLOWS, CG ;

AUBIN, JE ;

HEERSCHE, JNM .

ENDOCRINOLOGY, 1987, 121 (06) :1985-1992

[3] Characterization of 11β-hydroxysteroid dehydrogenase activity and corticosteroid receptor expression in human osteosarcoma cell lines [J].

Bland, R ;

Worker, CA ;

Noble, BS ;

Eyre, LJ ;

Bujalska, IJ ;

Sheppard, MC ;

Stewart, PM ;

Hewison, M .

JOURNAL OF ENDOCRINOLOGY, 1999, 161 (03) :455-464

[4] OSTEOPONTIN-HYDROXYAPATITE INTERACTIONS IN-VITRO - INHIBITION OF HYDROXYAPATITE FORMATION AND GROWTH IN A GELATIN-GEL [J].

BOSKEY, AL ;

MARESCA, M ;

ULLRICH, W ;

DOTY, SB ;

BUTLER, WT ;

PRINCE, CW .

BONE AND MINERAL, 1993, 22 (02) :147-159

[5] Fourier transform infrared microspectroscopic analysis of bones of osteocalcin-deficient mice provides insight into the function of osteocalcin [J].

Boskey, AL ;

Gadaleta, S ;

Gundberg, C ;

Doty, SB ;

Ducy, P ;

Karsenty, G .

BONE, 1998, 23 (03) :187-196

[6] Osteopontin deficiency increases mineral content and mineral crystallinity in mouse bone [J].

Boskey, AL ;

Spevak, L ;

Paschalis, E ;

Doty, SB ;

McKee, MD .

CALCIFIED TISSUE INTERNATIONAL, 2002, 71 (02) :145-154

[7] Mechanisms of glucocorticoid action in bone: Implications to glucocorticoid-induced osteoporosis [J].

Canalis, E .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (10) :3441-3447

[8] Mechanisms of glucocorticoid action in bone [J].

Canalis, E ;

Delany, AM .

NEUROENDOCRINE IMMUNE BASIS OF THE RHEUMATIC DISEASES II, PROCEEDINGS, 2002, 966 :73-81

[9] 11β-hydroxysteroid dehydrogenase, an amplifier of glucocorticoid action in osteoblasts [J].

Canalis, E ;

Delany, AM .

JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 (06) :987-990

[10] Inhibition of growth and differentiation of osteoprogenitors in mouse bone marrow stromal cell cultures by increased donor age and glucocorticoid treatment [J].

Chen, TL .

BONE, 2004, 35 (01) :83-95

← 1 2 3 4 5 6 →